Clinical Trials Browser

Phase 1 × pixantrone × Other hematologic neoplasm × Clear all

NCT00060684 2015-01-19

Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma

Phase 1 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell